A Translational Approach to Identify Drugs with Specific Activity Against EZH2 Mutant High Risk T-ALLs and ETP ALLs that Overexpress the JDP2 bZIP Transcription Factor |
Dana-Farber Cancer Institute / Shuning He, PhD |
Young Investigator Grants |
2015 |
Massachusetts |
Investigating the Role of the RNA Binding Protein LIN28 in Neuroblastoma |
Boston Children’s Hospital / John Powers |
Young Investigator Grants |
2012 |
Massachusetts |
Divergent Core Transcriptional Regulatory Circuitries to Highlight Context-Specific Vulnerabilities in AML |
Dana-Farber Cancer Institute / Maxim Pimkin, MD/PhD |
Young Investigator Grants |
2018 |
Massachusetts |
A mouse model of Wilms' Tumor
|
Massachusetts General Hospital / Nabeel Bardeesy, PhD |
Young Investigator Grants |
2008 |
Massachusetts |
Investigating the role of lin-28 in germ cell tumorigenesis
|
Boston Children’s Hospital / George Daley |
Innovation Grants |
2009 |
Massachusetts |
Using zebrafish to model the molecular origins of pediatric myeloid malignancies and acute myeloid leukemia |
Dana-Farber Cancer Institute / Evisa Gjini |
Young Investigator Grants |
2011 |
Massachusetts |
Targeted Therapy for Core Binding Factor Leukemia |
University of Massachusetts Medical School / John Pulikkan, PhD |
Young Investigator Grants |
2014 |
Massachusetts |
Regulation of Hematopoietic Stem Cell Engraftment by the Endothelial Cell Niche |
Boston Children’s Hospital / Bradley Blaser, MD, PhD |
Young Investigator Grants |
2015 |
Massachusetts |
The Therapy-Related Symptom Checklist for Children (TRSC-C): Systematic Monitoring of Symptoms to Improve Oncology Interventions.
|
Kansas Medical Center Research Institute, Inc. / Phoebe Williams |
Nurse Researcher Grants |
2008 |
Kansas |
MDM2 as an Effector of Hedgehog Signaling in Brain Development and Medulloblastoma
|
Purdue University / Susan Mendrysa, PhD |
Young Investigator Grants |
2008 |
Indiana |